Tecaginlimab (BNT-312), an Fc-inert bispecific antibody, is designed for the dual targeting and conditional activation of CD40 and 4-1BB, aiming to improve the priming and reactivation of tumor-specific immunity [1].
CAS Number:
[2253891-70-0]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
